David L Scott
Overview
Explore the profile of David L Scott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
4688
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kingsbury S, Tharmanathan P, Keding A, Watt F, Scott D, Roddy E, et al.
Ann Intern Med
. 2024 Jul;
177(9):1145-1156.
PMID: 39074374
Background: Treatments for osteoarthritis (OA) are limited. Previous small studies suggest that the antirheumatic drug methotrexate may be a potential treatment for OA pain. Objective: To assess symptomatic benefits of...
2.
Sweet A, Connelly C, Dewey E, Scott D
Prog Transplant
. 2023 Nov;
33(4):341-347.
PMID: 37964564
Renal allograft hypothermic machine perfusion results in a decreased incidence of delayed graft function compared with static cold storage. Ensuring perfusate temperatures remain within the target range of 4-10 °C...
3.
Ibrahim F, Scott I, Scott D, Ayis S
BMC Rheumatol
. 2023 Sep;
7(1):33.
PMID: 37749588
Background: Traditionally rheumatoid arthritis (RA) trials classify patients as responders and non-responders; they ignore the potential range of treatment responses. Group Based Trajectory Models (GBTMs) provide a more refined approach....
4.
Ibrahim F, Tom B, Scott D, Prevost A
Ther Adv Musculoskelet Dis
. 2022 Sep;
14:1759720X221114103.
PMID: 36148396
Background: Composite measures, like the Disease Activity Score for 28 joints (DAS28), are key primary outcomes in rheumatoid arthritis (RA) trials. DAS28 combines four different components in a continuous measure....
5.
Ibrahim F, Ma M, Scott D, Scott I
Arthritis Res Ther
. 2022 Sep;
24(1):218.
PMID: 36088424
Background: Pain is the main concern of patients with rheumatoid arthritis (RA) while reducing disease activity dominates specialist management. Disease activity assessments like the disease activity score for 28 joints...
6.
Lee S, Ibrahim F, Tom B, Nikiphorou E, Williams F, Lempp H, et al.
Arthritis Res Ther
. 2021 Nov;
23(1):278.
PMID: 34736525
Background: Clinical trials show intensive treatment to induce remission is effective in patients with highly active rheumatoid arthritis (RA). The TITRATE trial showed that the benefits of intensive treatment also...
7.
Nikiphorou E, Ibrahim F, Scott D
J Rheumatol
. 2021 Mar;
48(7):960-962.
PMID: 33722954
No abstract available.
8.
9.
Lempp H, Baggott R, Scott D, Parker L, Bosworth A, Georgopoulou S, et al.
Musculoskeletal Care
. 2020 Mar;
18(3):245-255.
PMID: 32222059
Background: As rheumatology nurses make substantial contributions to intensive management programmes following 'treat to target' principles of people with rheumatoid arthritis (RA), there is a need to understand the impacts...
10.
Mian A, Ibrahim F, Scott D
BMC Rheumatol
. 2019 Oct;
3:42.
PMID: 31660534
Background: We systematically reviewed current guidelines for managing rheumatoid arthritis (RA) to evaluate their range and nature, assess variations in their recommendations and highlight divergence in their perspectives. Methods: We...